Standard BioTools, Inc. (LAB)
0.6056
-0.03
(-4.72%)
USD |
NASDAQ |
Oct 23, 16:00
0.6001
-0.01
(-0.91%)
After-Hours: 20:00
Standard BioTools Enterprise Value : -211.16M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -211.16M |
| October 22, 2026 | -199.40M |
| October 21, 2026 | -193.75M |
| October 20, 2026 | -198.73M |
| October 19, 2026 | -196.38M |
| October 16, 2026 | -201.99M |
| October 15, 2026 | -190.46M |
| October 14, 2026 | -200.81M |
| October 13, 2026 | -190.26M |
| October 12, 2026 | -190.69M |
| October 09, 2026 | -178.30M |
| October 08, 2026 | -185.79M |
| October 07, 2026 | -182.50M |
| October 06, 2026 | -165.52M |
| October 05, 2026 | -149.44M |
| October 02, 2026 | -156.62M |
| October 01, 2026 | -163.05M |
| September 30, 2026 | -158.23M |
| September 29, 2026 | -168.93M |
| September 28, 2026 | -163.44M |
| September 25, 2026 | -158.50M |
| September 24, 2026 | -157.29M |
| September 23, 2026 | -157.68M |
| September 22, 2026 | -154.62M |
| September 21, 2026 | -157.72M |
| Date | Value |
|---|---|
| September 18, 2026 | -146.78M |
| September 17, 2026 | -162.38M |
| September 16, 2026 | -170.58M |
| September 15, 2026 | -177.95M |
| September 14, 2026 | -175.52M |
| September 11, 2026 | -178.07M |
| September 10, 2026 | -178.19M |
| September 09, 2026 | -163.56M |
| September 08, 2026 | -177.28M |
| September 04, 2026 | -179.83M |
| September 03, 2026 | -184.38M |
| September 02, 2026 | -184.62M |
| September 01, 2026 | -193.56M |
| August 31, 2026 | -190.34M |
| August 28, 2026 | -196.93M |
| August 27, 2026 | -192.58M |
| August 26, 2026 | -193.05M |
| August 25, 2026 | -193.75M |
| August 24, 2026 | -193.75M |
| August 21, 2026 | -186.30M |
| August 20, 2026 | -195.20M |
| August 19, 2026 | -185.28M |
| August 18, 2026 | -189.05M |
| August 17, 2026 | -180.23M |
| August 14, 2026 | -169.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 42.04B |
| Agilent Technologies, Inc. | 50.99B |
| Bio-Rad Laboratories, Inc. | 9.642B |
| Bruker Corp. | 10.43B |
| Danaher Corp. | 184.25B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.52M |
| Revenue (Quarterly) | 20.10M |
| Total Expenses (Quarterly) | 41.63M |
| EPS Diluted (Quarterly) | -0.0685 |
| Gross Profit Margin (Quarterly) | 52.40% |
| Profit Margin (Quarterly) | -107.1% |
| Earnings Yield | -37.24% |
| Normalized Earnings Yield | -27.44 |